Skip to content
DataLookout
Menu

NCT05154253

Augmenting Ankle Plantarflexor Function in Cerebral Palsy

StatusCompleted
PhasePhase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 6 words Show 4 more changesShow less
    • Primary endpoints: details revised at 3 of 32 entries
    • Trial completed
    • Site details revised
    • Collaborators: details revised at 1 of 2 entries
  2. Minor Primary completion date: May 8, 2026 to Sep 14, 2026v6
  3. Notable Eligibility criteria revisedv5
  4. Notable Start date: Oct 4, 2022 to Feb 1, 2023v4
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 4, 2022 to Oct 4, 2022
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in preferred walking speed
Timeframe: Immediately after the intervention
Change in similarity of plantarflexor muscle activity
Timeframe: Immediately after the intervention
Change in 6-minute-walk-test distance
Timeframe: Immediately after the intervention
Change in variance in muscle activity
Timeframe: Immediately after the intervention
Change in stride length
Timeframe: Immediately after the intervention
Change in stride-to-stride variability stride length
Timeframe: Immediately after the intervention
Change in walking posture
Timeframe: Immediately after the intervention
Change in Gross Motor Function Measure-66 sec. D&E
Timeframe: Immediately after the intervention
Change in plantar-flexor strength
Timeframe: Immediately after the intervention
Distance traveled
Timeframe: 1 day
Metabolic cost of transport from indirect calorimetry
Timeframe: 1 day
Subject perceived exertion
Timeframe: 1 day
Average muscle activity
Timeframe: 1 day
Heart Rate
Timeframe: 1 day

Arms and interventions

Device resisted gait training (treatment)Experimental

We will conduct a randomized controlled trial (treatment vs. control) to compare functional outcomes following bilateral targeted ankle resistance training (2 visits/week for 12 weeks) vs. dose-matched standard functional gait training.

Standard gait training (control)Experimental

We will conduct a randomized controlled trial (treatment vs. control) to compare functional outcomes following bilateral targeted ankle resistance training (2 visits/week for 12 weeks) vs. dose-matched standard functional gait training.

Comparison to Standard PT (within subjects control)Experimental

We will use a within-subject repeated measures design to compare both gait training groups to matched standard physical therapy.

Device assisted ambulationExperimental

We will compare task capacity and performance with adaptive ankle assistance vs. standard ankle foot orthoses and vs. shod (no ankle aid).

Passive brace assisted ambulationExperimental

We will compare task capacity and performance with adaptive ankle assistance vs. standard ankle foot orthoses and vs. shod (no ankle aid).

No ankle aid ambulationExperimental

We will compare task capacity and performance with adaptive ankle assistance vs. standard ankle foot orthoses and vs. shod (no ankle aid).

Devices: Biomotum Spark: Robotic ankle assistance, Biomotum Spark: Robotic ankle resistance, Ankle foot orthosis

Other: Standard gait training, Standard physical therapy, Standard walking

Sites

1 site in 1 country

  • Gillette Children's Specialty HealthcareMinneapolis, Minnesota, United States